DHF reduces clinical severity in EAE.
DHF suppresses inflammation and alters the cytokine profile in the CNS of EAE.
DHF reduces demyelination and axonal damage, and promotes remyelination in the CNS of EAE.
DHF reduces apoptosis in the CNS of EAE.
DHF activates TrkB-AKT-STAT3 pathway in the CNS of EAE.